Book a Consultation
Service

Chelation Therapy in Weatherford, Brock & Fort Worth, TX

Chelation therapy with DMSA, Calcium EDTA, and vitamin support for heavy metal detoxification and wellness optimization at Straight 2 U Wellness.
Schedule Your Consultation

What is Chelation Therapy?

Chelation therapy utilizes specialized compounds that bind to certain metals and facilitate their elimination from the body.

At Straight 2 U Wellness, protocols may include:

  • Calcium EDTA
  • DMSA
  • Vitamin C
  • Mineral replacement support
  • Personalized detoxification planning
Note: Chelation therapy is individualized based on testing, history, symptoms, and treatment goals.

Why Consider Heavy Metal Testing?

Exposure may occur through:

  • Smoking history
  • Industrial occupations
  • Environmental exposure
  • Water contamination
  • Certain consumer products

Common metals evaluated include:

  • Lead
  • Mercury
  • Cadmium
  • Arsenic

Frequently Asked Questions

Chelation FAQ

What is chelation therapy?
Chelation therapy utilizes specialized compounds that bind to certain metals and facilitate their elimination from the body.
Calcium disodium EDTA is one of the most commonly used chelating agents and has been utilized for decades in the treatment of heavy metal exposure.
DMSA is an oral chelating agent commonly used to support removal of certain heavy metals, particularly lead and mercury.
Yes. Tobacco smoke is a known source of cadmium, lead, arsenic, and other toxic metals. Former smokers may choose to evaluate their heavy metal burden as part of a comprehensive wellness plan.
Research has suggested that long-term exposure to metals such as lead and cadmium may contribute to oxidative stress, vascular dysfunction, and cardiovascular risk.
Chelation therapy should not be viewed as a treatment for coronary artery disease or a guaranteed method of reducing coronary calcium scores. However, interest in cardiovascular applications increased following findings from the TACT and TACT2 studies, which investigated EDTA chelation in certain high-risk patient populations. These studies demonstrated potential cardiovascular outcome benefits in selected groups, particularly patients with diabetes and prior cardiovascular disease. More research is ongoing, and treatment decisions should be individualized.
The Trial to Assess Chelation Therapy (TACT) and TACT2 were large clinical studies evaluating EDTA chelation therapy in patients with prior cardiovascular disease. The studies generated significant interest regarding the potential role of chelation therapy in cardiovascular risk reduction, although professional opinions continue to vary.
When properly administered and monitored by trained healthcare professionals, chelation therapy is generally considered safe. Appropriate patient screening, laboratory evaluation, hydration, and mineral replacement are important components of treatment.
Treatment recommendations vary based on heavy metal burden, symptoms, goals, laboratory findings, and exposure history.
Testing is often recommended to better understand your exposure history and determine whether chelation therapy may be appropriate.